ArticleMass spectrometry (Tokyo, Japan)2026
A Practical Workflow for Reliable MALDI-Based Hydrogen/Deuterium Exchange Mass Spectrometry.
Article in Mass spectrometry (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Matrix-assisted laser desorption/ionization-based hydrogen/deuterium exchange mass spectrometry (MALDI-HDX-MS) can provide peptide-level information on protein conformational dynamics without any specialized liquid chromatography (LC)-HDX instrumentation. Accurate interpretation of structure-dependent deuterium incorporation and reproducible MALDI-HDX measurements require minimization of unintended exchange and spectral variability during MALDI sample preparation and acquisition. Appropriate control of matrix crystallization, humidity, and spectral acquisition timing is therefore essential for reliable MALDI-HDX analysis. In this Technical Report, we describe a practical workflow for reliable MALDI-HDX measurements using human adenylate kinase 1 (AK1) as a model protein. The workflow includes humidity-controlled spotting on a precooled MALDI plate, preparation of a precooled α-cyano-4-hydroxycinnamic acid matrix solution, rapid vacuum-assisted drying, and time-controlled spectral acquisition. Precooling of the matrix solution induced visible two-layer separation, and use of the lower layer produced relatively uniform, small crystal clusters and favorable MALDI spectra. The influence of acquisition timing after matrix drying was evaluated using AK1 peptic fragments. For a peptide fragment sensitive to post-drying forward exchange, a small but detectable increase in deuterium incorporation was observed at 15 min after the start of matrix drying, whereas no substantial change was observed at 10 min compared with 5 min. Importantly, the increase caused by delayed acquisition was smaller than the difference in deuterium incorporation between structurally distinct peptide regions, indicating that structure-dependent HDX information was retained within the defined acquisition window. Establishment of practical matrix crystallization and spectral acquisition conditions will facilitate the reliable application of MALDI-HDX-MS to biological studies of protein conformational dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.